INVH vs RXRX · P/E 42, rev $1.48B vs rev $14.1M
Invitation Homes Inc (INVH) versus Recursion Pharmaceuticals Inc (RXRX) — a side-by-side from cached financials, not a winner call.
Invitation Homes Inc (INVH) is a reit - residential company listed on US.
Recursion Pharmaceuticals Inc (RXRX) is a biotechnology company listed on NASDAQ.
Latest reported INVH revenue for 2026-06-30 was $1.48B. Net income was $379.4M. INVH currently screens at market cap $19.99B and trailing P/E 41.8.
Latest reported RXRX revenue for 2026-06-30 was $14.1M. Net income was -$248.5M. RXRX currently screens at market cap $1.75B.
INVH currently screens at market cap $19.99B and trailing P/E 41.8. RXRX currently screens at market cap $1.75B.
Not investment advice. Open the INVH and RXRX stock pages for the full models.
Not investment advice.